213 related articles for article (PubMed ID: 27729184)
21. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
Yamada K; Miwa T; Liu J; Nangaku M; Song WC
J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
[TBL] [Abstract][Full Text] [Related]
22. Soluble CD59 expressed from an adenovirus in vivo is a potent inhibitor of complement deposition on murine liver vascular endothelium.
Gandhi J; Cashman SM; Kumar-Singh R
PLoS One; 2011; 6(6):e21621. PubMed ID: 21720565
[TBL] [Abstract][Full Text] [Related]
23. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression.
Dalmasso AP; Benson BA; Johnson JS; Lancto C; Abrahamsen MS
J Immunol; 2000 Apr; 164(7):3764-73. PubMed ID: 10725736
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
[TBL] [Abstract][Full Text] [Related]
25. Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes.
Qin X; Goldfine A; Krumrei N; Grubissich L; Acosta J; Chorev M; Hays AP; Halperin JA
Diabetes; 2004 Oct; 53(10):2653-61. PubMed ID: 15448097
[TBL] [Abstract][Full Text] [Related]
26. A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications.
Sahoo R; Ghosh P; Chorev M; Halperin JA
Am J Hematol; 2017 Nov; 92(11):1198-1203. PubMed ID: 28815695
[TBL] [Abstract][Full Text] [Related]
27. New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.
Schnabolk G; Beon MK; Tomlinson S; Rohrer B
J Ocul Pharmacol Ther; 2017 Jun; 33(5):400-411. PubMed ID: 28333572
[TBL] [Abstract][Full Text] [Related]
28. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
29. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
Soro-Paavonen A; Watson AM; Li J; Paavonen K; Koitka A; Calkin AC; Barit D; Coughlan MT; Drew BG; Lancaster GI; Thomas M; Forbes JM; Nawroth PP; Bierhaus A; Cooper ME; Jandeleit-Dahm KA
Diabetes; 2008 Sep; 57(9):2461-9. PubMed ID: 18511846
[TBL] [Abstract][Full Text] [Related]
30. Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes.
Fischetti F; Candido R; Toffoli B; Durigutto P; Bernardi S; Carretta R; Tedesco F; Fabris B
Atherosclerosis; 2011 May; 216(1):83-9. PubMed ID: 21367419
[TBL] [Abstract][Full Text] [Related]
31. [Effects and related mechanism of retinoid X receptor agonist bexarotene on atherosclerosis progression in diabetic apoE(-/-) mice].
Zhu J; Xu C; Ning R; Chai D; Lin J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):492-7. PubMed ID: 25164224
[TBL] [Abstract][Full Text] [Related]
32. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
33. Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout mice.
Qin X; Hu W; Song W; Blair P; Wu G; Hu X; Song Y; Bauer S; Feelisch M; Leopold JA; Loscalzo J; Halperin JA
Am J Hematol; 2009 Apr; 84(4):221-7. PubMed ID: 19229985
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
35. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
36. The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque.
Anderson DR; Tsutsui JM; Xie F; Radio SJ; Porter TR
Cardiovasc Res; 2007 Feb; 73(3):597-606. PubMed ID: 17196951
[TBL] [Abstract][Full Text] [Related]
37. Gal-geun-dang-gwi-tang improves diabetic vascular complication in apolipoprotein E KO mice fed a western diet.
Lee SM; Lee YJ; Choi JH; Kho MC; Yoon JJ; Shin SH; Kang DG; Lee HS
BMC Complement Altern Med; 2014 Nov; 14():453. PubMed ID: 25416139
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Sun H; Zhang X; Zhao L; Zhen X; Huang S; Wang S; He H; Liu Z; Xu N; Yang F; Qu Z; Ma Z; Zhang C; Zhang Y; Hu Q
J Cell Mol Med; 2015 Apr; 19(4):836-49. PubMed ID: 25661015
[TBL] [Abstract][Full Text] [Related]
39. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
40. Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes.
Wang Z; Guo W; Liu Y; Gong Y; Ding X; Shi K; Thome R; Zhang GX; Shi FD; Yan Y
Brain Behav Immun; 2017 Oct; 65():173-182. PubMed ID: 28476558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
